Unknown Renal Impairment: A Rare Case of Inhaled Tobramycin Induced Acute Kidney Injury in a Cystic Fibrosis Patient
Open Access
- 12 April 2021
- journal article
- case report
- Published by MDPI AG in Antibiotics
- Vol. 10 (4) , 424
Abstract
Acute kidney injury is a reversible medical condition commonly caused by nephrotoxic agents. The infrequency that a nebulized medication elicits a renal insult presents a rare diagnostic challenge. Within this case, we report a 57-year-old cystic fibrosis patient with chronic kidney disease (CKD) Stage G3b (baseline 1.5–1.6 mg/dL) who developed an acute kidney injury (AKI) with a serum creatinine elevation to 4.08 mg/dL and associated worsening vestibular dysfunction related to twice-daily nebulized tobramycin inhalation solution (TIS). The patient was found to have a tobramycin serum level of 4.2 μg/mL 2.5 h after TIS dosing, with elevation remaining present at 1.1 μg/mL 24 h after discontinuation of therapy. Laboratory values at one month continued to show elevated creatinine levels at 2.1 mg/dL, suggesting progression of his baseline CKD. This case supports the benefit of obtaining tobramycin serum levels and vestibular/audiology function testing when evaluating patients on chronic nebulized TIS who present with acute or chronic renal dysfunction. From these serum levels, adjustments to daily dosing, regular monitoring of tobramycin serum levels, or discontinuation of treatment should be made to prevent permanent renal damage in patients with CKD. Calculated Naranjo ADR Probability Scale: 9; Definite.Keywords
This publication has 27 references indexed in Scilit:
- Long‐term effect of chronic intravenous and inhaled nephrotoxic antibiotic treatment on the renal function of patients with cystic fibrosisHemodialysis International, 2012
- The severity of acute kidney injury predicts progression to chronic kidney diseaseKidney International, 2011
- Adverse drug reaction and causality assessment scalesLung India, 2011
- Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosisThorax, 2010
- Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesisThorax, 2007
- Acute renal failure associated with use of inhaled tobramycin for treatment of chronic airway colonization with Pseudomonas aeruginosaClinical Nephrology, 2006
- Acute renal failure associated with inhaled tobramycinAmerican Journal of Health-System Pharmacy, 2006
- Tacrolimus Pharmacokinetics and Dose Monitoring After Lung Transplantation for Cystic Fibrosis and Other ConditionsAmerican Journal of Transplantation, 2005
- Vestibular Toxicity Due to Inhaled Tobramycin in a Patient With Renal InsufficiencyMayo Clinic Proceedings, 2004
- Acute renal failure in cystic fibrosis: Association with inhaled tobramycin therapyPediatric Pulmonology, 2002